Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential.
Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Published Article
The Indian journal of chest diseases & allied sciences
- Publication Date
Jan 01, 2006
Alginate nanoparticles appear to have the potential for intermittent therapy of TB.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 01/12/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/18610673